CymitQuimica logo

CAS 263707-16-0

:

Ordinare per

Purezza (%)
0
100
|
0
|
50
|
90
|
95
|
100
Trovati 8 prodotti.
  • ESI-09

    CAS:
    2-(5-(tert-Butyl)isoxazol-3-yl)-N-(3-chlorophenyl)-2-oxoacetohydrazonoyl cyanide
    Formula:C16H15ClN4O2
    Purezza:98%
    Peso molecolare:330.77

    Ref: IN-DG630600

    5mg
    20,00€
    10mg
    26,00€
    25mg
    52,00€
    50mg
    78,00€
    100mg
    110,00€
    250mg
    185,00€
    1g
    466,00€
  • ESI-09

    CAS:
    ESI-09
    Formula:C16H15ClN4O2
    Purezza:98%
    Peso molecolare:330.77

    Ref: 54-OR1023846

    10mg
    66,00€
    25mg
    78,00€
    50mg
    98,00€
    100mg
    124,00€
    250mg
    222,00€
    1g
    550,00€
  • ESI-09

    CAS:
    ESI-09
    Formula:C16H15ClN4O2
    Purezza:≥95%
    Peso molecolare:330.77

    Ref: 54-BUP05730

    2mg
    57,00€
    5mg
    89,00€
    10mg
    134,00€
    25mg
    254,00€
    50mg
    432,00€
    100mg
    640,00€
  • ESI-09

    CAS:
    ESI-09 is a new-typel noncyclic nucleotide EPAC antagonist.The IC50 values of ESI-09 for EPAC1 and EPAC2 is 3.2 and 1.4 μM, respectively.
    Formula:C16H15ClN4O2
    Purezza:97.24% - 99.57%
    Colore e forma:Solid
    Peso molecolare:330.77

    Ref: TM-T2244

    2mg
    39,00€
    5mg
    58,00€
    1mL*10mM (DMSO)
    63,00€
    10mg
    93,00€
    25mg
    165,00€
    50mg
    289,00€
    100mg
    434,00€
  • ESI 09

    Prodotto controllato
    CAS:

    Applications ESI 09 acts as an EPAC inhibitor, preventing EPAC-mediated insulin release form β-pancreatic cells. Selective control for EPAC over PKA and decreases migration and invasion of AsPc-1 and PANC-1 pancreatic cancer cells.
    References Tao, X. et al.: J. Virol., 88, 3902 (2014); Almahariq, M. et al.: Mol. Pharm., 83, 122 (2013);

    Formula:C16H15ClN4O2
    Colore e forma:Neat
    Peso molecolare:330.769

    Ref: TR-E658950

    5mg
    137,00€
    10mg
    227,00€
    25mg
    430,00€
  • ESI-09

    CAS:
    Formula:C16H15ClN4O2
    Purezza:98%
    Colore e forma:Solid
    Peso molecolare:330.77

    Ref: 10-F547227

    1mg
    9,00€
    5mg
    21,00€
    10mg
    29,00€
    25mg
    51,00€
    50mg
    76,00€
    100mg
    102,00€
  • ESI-09

    CAS:
    ESI-09 is a novel drug candidate that has been shown to have synergistic effects with chemotherapeutic agents in the treatment of cancer. It is a potential drug target for cancer, and its anticancer activity may be due to its ability to reduce oxidative stress by activating antioxidant enzymes. ESI-09 has antioxidative properties and decreases the mitochondrial membrane potential, which leads to increased ATP levels. ESI-09 also has the ability to cause cell death by inhibiting aerobic glycolysis, which may be due to its inhibitory effects on the polymerase chain reaction (PCR).
    Formula:C16H15ClN4O2
    Purezza:Min. 95%
    Peso molecolare:330.77 g/mol

    Ref: 3D-NKA70716

    250mg
    443,00€
    2500mg
    1.584,00€
  • 3-Isoxazolepropanenitrile, α-[2-(3-chlorophenyl)hydrazinylidene]-5-(1,1-dimethylethyl)-β-oxo-

    CAS:
    Formula:C16H15ClN4O2
    Purezza:98%
    Colore e forma:Solid
    Peso molecolare:330.7689

    Ref: IN-DA002SX8

    5mg
    Fuori produzione
    10mg
    Fuori produzione
    25mg
    Fuori produzione
    50mg
    Fuori produzione
    100mg
    Fuori produzione
    250mg
    Fuori produzione
    1g
    Fuori produzione
    Prodotto fuori produzione